Beating the Blues
A Pelotonia-funded clinical trial evaluates an online therapy for cancer patients with depression
“Beating the Blues” is an online intervention designed to treat depression and anxiety. It is based on cognitive-behavioral therapy, and it provides ways to better manage mood, stress and anxiety, the researchers say.
The trial is funded by a Pelotonia postdoctoral fellowship awarded to Marlena Ryba, PhD, a postdoctoral researcher in the laboratory of OSUCCC – James researcher Barbara Andersen, PhD, professor of Psychology and a Distinguished University Professor.
“Promising findings indicate that this intervention may be suitable for a range of patients in diverse settings,” says Ryba, principal investigator for the trial. “Our trial is designed to determine whether Beating the Blues is effective in reducing depression in people with cancer.”
Depression affects 10 to 50 percent of cancer patients. Yet, it often goes undiagnosed, and when diagnosed, it is often undertreated.
“Depression can be a risk factor for premature mortality in cancer patients, and the need for psychosocial intervention can be important,” says OSUCCC – James researcher and principal investigator Barbara Andersen, PhD, professor of Psychology and a Distinguished University Professor.